SCHEDULE: Capital Research Global Investors Discloses Halliburton Stake

Capital Research Global Investors has reported a 6.7% ownership stake in Halliburton Co. as of March 31, 2026.

Summary

• Capital Research Global Investors (CRGI) has filed a Schedule 13G, indicating beneficial ownership of Halliburton Co. common stock.
• As of March 31, 2026, CRGI beneficially owns 56,355,626 shares of Halliburton's common stock.
• This represents approximately 6.7% of the total outstanding shares, which are estimated to be 837,548,345.
• CRGI has sole voting power over 56,343,722 shares and sole dispositive power over 56,355,626 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard disclosure of existing ownership rather than new strategic information or performance data.

Positives

• Significant institutional ownership by Capital Research Global Investors, a well-established investment management entity.
• Clear disclosure of beneficial ownership, providing transparency to the market.

Future Outlook

This filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that significant institutional filings like this Schedule 13G from major asset managers such as Capital Research Global Investors are common and provide insights into investor sentiment and holdings within the oilfield services sector.

Stakeholder Impact

• Shareholders gain transparency into the holdings of a significant institutional investor.
• The market receives confirmation of Capital Research Global Investors' substantial position in Halliburton.

Key Dates

Keywords

Halliburton Co., Capital Research Global Investors, Schedule 13G, Institutional Ownership, Common Stock, Beneficial Ownership, SEC Filing